Skip to main content

Full Schedule

Full Schedule

  • Friday, June 17, 2022
  • 1:00 PM – 2:35 PM
    Session I: WM I
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Presenter: Prashant Kapoor, MD – Mayo Clinic

    Presenter: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine

    Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 1:00 PM – 1:05 PM
    Welcome and Polling
    Time Zone: ET

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 1:05 PM – 1:25 PM
    The Genomics of Waldenström Macroglobulinemia
    Time Zone: ET

    Speaker: Prashant Kapoor, MD – Mayo Clinic

  • 1:25 PM – 1:45 PM
    Current and Emerging Treatment Options in Waldenström Macroglobulinemia
    Time Zone: ET

    Speaker: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine

  • 1:45 PM – 1:52 PM
    Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - BR
    Time Zone: ET

    Speaker: Prashant Kapoor, MD – Mayo Clinic

  • 1:52 PM – 1:59 PM
    Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - BTK
    Time Zone: ET

    Debate Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 1:59 PM – 2:05 PM
    Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - DISCUSSION
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 2:05 PM – 2:35 PM
    Q&A and Polling
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 2:35 PM – 2:55 PM
    Break
    Time Zone: ET
  • 2:55 PM – 4:30 PM
    Session II: WM II
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

    Presenter: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation

    Presenter: Prashant Kapoor, MD – Mayo Clinic

    Presenter: Shayna Sarosiek, MD – Dana Farber Cancer Institute

  • 2:55 PM – 3:00 PM
    Welcome and Polling
    Time Zone: ET

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 3:00 PM – 3:20 PM
    Role of BTK inhibitors in Waldenström Macroglobulinemia
    Time Zone: ET

    Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 3:20 PM – 3:40 PM
    Treatment Adherence: A Patient's Perspective
    Time Zone: ET

    Speaker: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation

  • 3:40 PM – 4:00 PM
    Case Discussion: When to Wait and When to Treat
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute

  • 4:00 PM – 4:30 PM
    Q&A and Polling
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute

    Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute